Breztri is a prescription medication used to manage chronic obstructive pulmonary disease (COPD). It contains a combination of two active ingredients: budesonide, a corticosteroid that reduces inflammation, and formoterol, a long-acting bronchodilator that helps open the airways. This combination helps improve breathing and reduce flare-ups in patients with COPD. Breztri is typically administered through an inhaler, making it easy for patients to use. It is important for users to follow their healthcare provider's instructions regarding dosage and frequency to ensure optimal results and minimize potential side effects. Regular use can lead to better control of COPD symptoms.